AA Ladak, S Sandhu, A Itrat - Journal of Stroke and Cerebrovascular …, 2021 - Elsevier
Objectives Our review aims to present existing data on the safety of Intravenous thrombolysis (IVT) use in acute ischemic stroke (AIS) patients with concomitant central …
E Zoga, R Wolff, H Ackermann, M Meissner, C Rödel… - Cancers, 2022 - mdpi.com
Simple Summary Melanoma brain metastases (MBM) have a high propensity for hemorrhage (HA) after treatment. Our retrospective analysis evaluated factors associated …
Background Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare non–Langerhans cell reactive histiocytic disorder that rarely …
Readmission following inpatient stereotactic radiosurgery for brain tumors - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
MJ Colditz, SF Lee, M Eastgate, S Elder… - Interdisciplinary …, 2021 - Elsevier
Background Major advances in the systemic treatment of metastatic cerebral melanoma have improved patient survival. The clinical relationship between gross total resection …
G Noel, A Keller, D Antoni - Cancer/Radiothérapie, 2019 - Elsevier
Résumé La radiothérapie en conditions stéréotaxiques des métastases cérébrales est un traitement reconnu comme efficace, bien toléré, applicable pour des indications …
E Spasic, I Buchheit, V Bernier, A Noel - Cancer/Radiothérapie, 2011 - Elsevier
Résumé Objectif de l'étude Effectuer une comparaison entre la radiothérapie conformationnelle tridimensionnelle, la radiothérapie conformationnelle avec modulation …
-BACKGROUND: Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare noneLangerhans cell reactive histiocytic disorder that …